The association of FGF23 levels in obese adolescents with insulin sensitivity

Journal of Pediatric Endocrinology and Metabolism

Volumn 25, Issue 7-8, 2012, Pages 687-690

  Wojcik, Malgorzata ^a   Janus, Dominika ^a   Dolezal Oltarzewska, Katarzyna ^a   Drozdz, Dorota ^a   Sztefko, Krystyna ^b   Starzyk, Jerzy B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Adolescents; FGF23; Insulin resistance; Obesity

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GLUCOSE; INSULIN;

ADOLESCENT; ADOLESCENT DISEASE; ARTICLE; BLOOD ANALYSIS; CHILDHOOD OBESITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AGE OF ONSET; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INSULIN RESISTANCE; MALE; OBESITY;

EID: 84867758115     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0064     Document Type: Article

References (18)

1. Kharitonenkov A. FGFs and metabolism. Curr Opin Pharmacol 2009;9:805-10.
2. Wojcik M, Dolezal-Oltazewska K, Janus D, Drozdz D, Sztefko K, et al. FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results. Clin Endocrinol (Oxf) 2011;22:DOI: 10.1111/j.1365-2265.2011.04299.x.
3. Mirza MA, Alsiö J, Hammarstedt A, Erben RG, Michaë lsson K, et al. Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals. Arterioscler Thromb Vasc Biol 2011;31:219-27.
4. Mirza MA, Larsson A, Melhus, Lind L, Larsson TE. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis 2009;207:546-51.
5. Goła̧b S, Chrzanowska M, editors. Dziecko Krakowskie 2000. Poziom rozwoju biologicznego dzieci i młoszieży Miasta Krakowa. Kraków: AWF, 2002.
6. Drozdz D, Kwinta P, Pietrzyk JA, Korohoda P, Drozdz M, et al. Body mass index (BMI) or bioimpedance analysis (BIA) - which method enables a better assessment of fat mass in children? Przegl Lek 2007;64(Suppl 3):68-7.
7. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-3.
8. Prié D, Friedlander G. Reciprocal control of 1, 25-dihydroxyvitamin D and FGF23 formation involvingg the FGF23/Klotho system. Clin J Am Soc Nephrol 2010;5:1717-22.
9. Marsell R, Mirza MA, Mallmin H, Karlsson M, Mellström D, et al. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men. Osteoporos Int 2009;20:1167-73.
10. Ashikaga E, Honda H, Suzuki H, Hosaka N, Hirai Y, et al. Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients. Ther Apher Dial 2010;14:315-22.
11. Martin A, David A, Quarles LD. Regulation and function of the fgf23/klotho endocrine pathways. Physiol Rev 2012;92:131-55.
12. Razzaque MS, Sitara D, Taguchi T, St-Arnaud R, Lanske B, et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006;20:720-2.
13. Lorenzi O, Veyrat-Durebex C, Wollheim CB, Villemin P, Rohner-Jeanrenaud F, et al. Evidence against a direct role of klotho in insulin resistance. Pflugers Arch 2010;459:465-73.
14. Streicher C, Zeitz U, Andrukhova O, Rupprecht A, Pohl E, et al. Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor. Endocrinology 2012;153:1795-805.
15. Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes 2012;36:387-96.
16. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010;17:113-9.
17. Swales HH, Wang TJ. Vitamin D and cardiovascular disease risk: emerging evidence. Curr Opin Cardiol 2010;25:513-7.
18. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012;95:1055-9.